Bio Protocol vs SuperRare — how do they compare? Bio Protocol trades at Rp514.26 (market cap Rp1,16T, Rp252,63M 24h volume), while SuperRare trades at Rp226.06 (market cap Rp185,48M, Rp130,48M 24h volume). The key difference: Bio Protocol is far larger — about 6254× SuperRare's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 825,5M / 1B RARE (83%) for SuperRare. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and SuperRare for 30 Days on average.
| BIO | RARE | |
|---|---|---|
Market Cap | Rp1,16T | Rp185,48M |
Volume (24h) | Rp252,63M | Rp130,48M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 825,5M / 1B RARE (83%) |
Typical Hold Time | 16 Days | 30 Days |
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →SuperRare is the leading curated marketplace for on-chain art, with more than US$300M in total sales and US$180M earned by artists. As one of the earliest champions of perpetual artist royalties, SuperRare is working to improve discovery while decentralizing the art market. Core to SuperRare is $RARE, a token offering utility as a currency on the marketplace, a staking-based reputation system, and DAO governance rights.
Read more on RARE →